Concepedia

Jin Zhang

JZ

Statistics

Publications

5

Citations

193

H-Index

5

Active since

2016

Affiliations

Tianjin Medical University Cancer Institute and Hospital(Current)

Hammersmith Hospital

Imperial College London

Jin Zhang is an author at Tianjin Medical University Cancer Institute and Hospital specializing in molecular oncology, oncology, and medicine.

ORCID

Publications per year

2016–2021

5

Publications

5

Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer

Yunhui Hu, Ernesto Yagüe, Jing Zhao et al. · Cancer Letters · 2018 · 82 citations · Full text

, , +17

Centromere protein U (CENPU) enhances angiogenesis in triple-negative breast cancer by inhibiting ubiquitin–proteasomal degradation of COX-2

Teng Pan, Dongdong Zhou, Zhendong Shi et al. · Cancer Letters · 2019 · 39 citations

, , +15

Chidamide Combined With Doxorubicin Induced p53-Driven Cell Cycle Arrest and Cell Apoptosis Reverse Multidrug Resistance of Breast Cancer

Lixia Cao, Shaorong Zhao, Qianxi Yang et al. · Frontiers in Oncology · 2021 · 25 citations · Full text

, , +15

GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation

Jingjing Liu, Lei Liu, Ernesto Yagüe et al. · Breast Cancer Research and Treatment · 2018 · 24 citations

, , +11

GGNBP2 acts as a tumor suppressor by inhibiting estrogen receptor α activity in breast cancer cells

Zi‐Jian Lan, YunHui Hu, Sheng Zhang et al. · Breast Cancer Research and Treatment · 2016 · 23 citations

, , +14

1–5 of 5